Add Trial
Sign In

MERU / M16-298 - Hosted By

Sponsor Name
Tumor Site Small Cell Lung Cancer
Disease Stage Stage IV
Clinical Status Maintenance Therapy
Phase Phase III
Intervention / Treatment Rovalpituzumab Teserine
Research Site Quebec
Investigator Dre Lise Tremblay
Telephone Number 418-656-8711 ext 2639
Study Start Date January 26, 2017
Study End Date November 30, 2019
Trial Status Recruitment Complete


Working Hours :

Now Closed UTC - 4
  • MondayDay Off
  • TuesdayDay Off
  • WednesdayDay Off
  • ThursdayDay Off
  • FridayDay Off
  • SaturdayDay Off
  • SundayDay Off

Price / Claim :

Recruit a patient:

*for confidentiality, do not include the name of the patient

*pour raisons de confidentialité, n'incluez pas le nom du patient

Hosted by :

More from this author :

Claim listing: MERU / M16-298

Our website is under development. We're sorry for any inconvenience that might appear.Notre site web est en cours de développement. Nous sommes désolés pour tout inconvénient qui pourrait survenir.

Reply to Message


Please select an account type above.

Account details will be confirmed via email.

Register with us by filling out the form below.
Register with us by filling out the form below.

Reset Your Password